PharmaCorp Rx Income Statement

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Selling, General & Admin	1.87	0.58	0.18	0.08
Operating Expenses	2.7	0.58	0.56	0.08
Operating Income	-2.19	-0.58	-0.56	-0.08
Interest & Investment Income	0.22	0.11	0.05	0
Pretax Income	-1.99	-0.47	-0.52	-0.08
Net Income	-1.99	-0.47	-0.52	-0.08
Net Income to Common	-1.99	-0.47	-0.52	-0.08
Shares Outstanding (Basic)	117	20	20	16
Shares Outstanding (Diluted)	117	20	20	16
Shares Change (YoY)	476.74%	1.39%	23.69%	-
EPS (Basic)	-0.02	-0.02	-0.03	-
EPS (Diluted)	-0.02	-0.02	-0.03	-
EBIT	-2.19	-0.58	-0.56	-0.08
Revenue as Reported	0.11	0.11	0.05	0

Updated Nov 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.